According to the market research, the sales value of Goserelin in the Chinese market has increased year by year since 2016-2020, with the CAGR from 2016 to 2019 is around 18%. In 2020, due to the impact of COVID-19 on the overall diagnosis and treatment services of Chinese hospitals, the annual growth rate of Goserelin’s sales value dropped to 8.76% in 2020. However, the sales value of Goserelin in the Chinese market reached CNY990 million in 2020 and the CAGR of the sales value of Goserelin in the Chinese market is 15.94% from 2016 to 2020.
The analyst predicts that with the increase in the number of patients with indications, the sales volume of Goserelin will steadily increase from 2021 to 2025. In 2020, the number of new breast cancers worldwide reached 2.26 million, and the number of prostate cancers was 1.41 million, both of which were on the rise. Therefore, the sales volume of Goserelin for the treatment of breast cancer and prostate cancer increased with the increase in the number of patients diagnosed with breast cancer and prostate cancer, and its sales also increased. China has approved Luye Pharmaceuticals to conduct generic drug clinical trials and has successfully conducted Phase III clinical trials at the end of 2020. It is expected that the generic drug will be launched in the next five years. As a result, the price of Goserelin will continue to fall, sales and sales volume will also have certain upside potential. In addition, the effective alleviation of COVID-19 will also cause a recovery growth in the sales of Goserelin.
- The impact of COVID-19 on China's Goserelin market
- Sales value of China's Goserelin 2016-2020
- Competitive landscape of China's Goserelin market
- Prices of Goserelin in China
- Prices of Goserelin in China by regions and manufacturers
- Analysis of factors affecting the development of China's Goserelin market
- Prospect of China's Goserelin market from 2021 to 2025
1.1 Indications for Goserelin
1.2 Development of Goserelin in China
1.3 Governmental Approval of Goserelin in China
1.4 The Impact of COVID-19 on Goserelin sales in China
2 Sales of Goserelin in China, 2016-2020
2.1 Sales Value of Goserelin
2.1.1 Overall Sales Value
2.1.2 Sales Value by Region
2.2 Sales Volume of Goserelin
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Region
2.3 Sales of Goserelin by Dosage Form in China, 2016-2020
2.3.1 Sustained-release Implant Injection
2.3.2 Analysis of Other Dosage Forms
3 Analysis of Major Goserelin Manufacturers in China, 2016-2020
3.1 Analysis of Market Share of Major Goserelin Manufacturers
3.1.1 Investigation on Market Share by Sales Value
3.1.2 Investigation on Market Share by Sales Volume
3.2 AstraZeneca UK Ltd
3.2.1 Enterprise Profile
3.2.2 Sales of ZOLADEX (AstraZeneca UK Ltd’s Goserelin) in China
4 Prices of Goserelin for Different Manufacturers in China, 2020-2021
4.1 AstraZeneca UK Ltd (ZOLADEX)
4.2 Analysis of Other Manufacturers
5 Prospect of Chinese Goserelin Market, 2021-2025
5.1 Influential Factors of Chinese Goserelin Market Development
5.1.1 The Impact of COVID-19 on Chinese Goserelin Market
5.1.2 Market Drivers and Opportunities
5.1.3 Market Threats and Challenges
5.2 Forecast on Market Size
5.3 Forecast on Market Trend
List of Charts
Chart Patent Information About Goserelin Sustained-release Implant Injection Registration in China
Chart Sales Value of Goserelin Sustained-release Implant Injection over the World
Chart Sales Value of Goserelin Sustained-release Implant Injection in China, 2016-2020
Chart Sales Value of Goserelin Sustained-release Implant Injection in China by Region, 2016-2020
Chart Sales Volume of Goserelin Sustained-release Implant Injection in China, 2016-2020
Chart Sales Volume of Goserelin Sustained-release Implant Injection in China by Region, 2016-2020
Chart Market Share by Sales Value of Top Goserelin Manufacturers in China, 2016-2020
Chart Sales Value and Volume of ZOLADEX in China, 2016-2020
Chart Referential Prices of ZOLADEX in China by Region, 2020-2021
Chart Forecast on Sales Value of Goserelin in China, 2021-2025
Chart Forecast on Sales Volume of Goserelin in China, 2021-2025
- AstraZeneca UK Ltd
Background research defines the range of products and industries, which proposes the key points of the research. Proper classification will help clients understand the industry and products in the report.
Secondhand material research is a necessary way to push the project into fast progress. The analyst always chooses the data source carefully. Most secondhand data they quote is sourced from an authority in a specific industry or public data source from governments, industrial associations, etc. For some new or niche fields, they also "double-check" data sources and logics before they show them to clients.
Primary research is the key to solve questions, which largely influence the research outputs. The analyst may use methods like mathematics, logical reasoning, scenario thinking, to confirm key data and make the data credible.
The data model is an important analysis method. Calculating through data models with different factors weights can guarantee the outputs objective.
The analyst optimizes the following methods and steps in executing research projects and also forms many special information gathering and processing methods.
1. Analyze the life cycle of the industry to understand the development phase and space.
2. Grasp the key indexes evaluating the market to position clients in the market and formulate development plans
3. Economic, political, social and cultural factors
4. Competitors like a mirror that reflects the overall market and also market differences.
5. Inside and outside the industry, upstream and downstream of the industry chain, show inner competitions
6. Proper estimation of the future is good guidance for strategic planning.